General description
INN
Erythromycin
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1977
(TRS
615)
for
Bacterial infection of unspecified site
Added in 2017
(TRS
1006)
for
Gonococcal infection of eye
Added in 2017
(TRS
1006)
for
Chlamydial conjunctivitis
Removed in 2017
(TRS
1006)
for
Bacterial infection of unspecified site
Changed in 2021
(TRS
1035)
for
Acute pharyngitis
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Ophthalmological preparations > Anti-infective agents
- Local > Ophthalmological > Ointment: 0.5%
Indications
Section
Watch group antibiotics
- Parenteral > General injections > IV: 500 mg in vial powder for injection (as lactobionate)
- Oral > Liquid: 125 mg per 5 mL (as stearate or ethylsuccinate)
- Oral > Solid: 250 mg (as stearate or ethylsuccinate)
Indications